@article{79f09b04732c4fc3aeb106eea29c108c,
title = "Surviving ovarian cancer: An affair between defective DNA repair and RB1",
abstract = "Detailed clinical and molecular evaluation of large cohorts of exceptional survivors provides an unprecedented opportunity to identify mechanisms underlying long-term survival that can drive future therapeutic approaches and biomarker development. Exceptional survivors of high-grade serous ovarian cancer demonstrate concurrent disruption of homologous recombination DNA repair and retinoblastoma protein.",
author = "Guang Peng and Mills, {Gordon B.}",
note = "Funding Information: This research was supported by NCI Cancer Center Support Grant CA016672 to The University of Texas MD Anderson Cancer Center, Department of Defense grant OC140431, NIH R01 grant CA181663 to G. Peng, and Cancer Prevention and Research Institute of Texas grant RP160242 to G. Peng. G.B. Mills received a gift from the Adelson Medical Research Foundation. Publisher Copyright: {\textcopyright} 2017 American Association for Cancer Research.",
year = "2018",
month = feb,
day = "1",
doi = "10.1158/1078-0432.CCR-17-3022",
language = "English (US)",
volume = "24",
pages = "508--510",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "3",
}